European Neuropsychopharmacology

1

Psychiatric comorbidity of patients on methadone maintenance treatment with a history of sexual abuse

Peles, Einat, Potik, David, Schreiber, Shaul, Bloch, Miki, Adelson, Miriam

Journal:

Year:

2012

Language:

english

File:

PDF, 230 KB

english, 2012

2

Vortioxetine (Lu AA21004) in generalized anxiety disorder: Results of an 8-week, multinational, randomized, double-blind, placebo-controlled clinical trial

Bidzan, Leszek, Mahableshwarkar, Atul R., Jacobsen, Paula, Yan, Mingjin, Sheehan, David V.

Journal:

European Neuropsychopharmacology

Year:

2012

Language:

english

File:

PDF, 395 KB

english, 2012

3

On assessing potential efficacy for vortioxetine in generalized anxiety disorder

Baldwin, David S., Nutt, David J.

Journal:

European Neuropsychopharmacology

Year:

2012

Language:

english

File:

PDF, 166 KB

english, 2012

4

Pre-treatment waking cortisol response and vulnerability to interferon α induced depression

Eccles, Jessica, Lallemant, Camille, Mushtaq, Farrah, Greenwood, Matthew, Keller, Majella, Golding, Bruno, Tibble, Jeremy, Haq, Inam, Whale, Richard

Journal:

European Neuropsychopharmacology

Year:

2012

Language:

english

File:

PDF, 222 KB

english, 2012

5

Detection of the acute effects of hydrocortisone in the hippocampus using pharmacological fMRI

Symonds, Catherine S., McKie, Shane, Elliott, Rebecca, William Deakin, John Francis, Anderson, Ian M.

Journal:

European Neuropsychopharmacology

Year:

2012

Language:

english

File:

PDF, 556 KB

english, 2012

6

Effects of novel, high affinity glycine transport inhibitors on frontostriatal dopamine release in a rodent model of schizophrenia

Balla, Andrea, Schneider, Samantha, Sershen, Henry, Javitt, Daniel C.

Journal:

European Neuropsychopharmacology

Year:

2012

Language:

english

File:

PDF, 520 KB

english, 2012

7

Vortioxetine (Lu AA21004) 5mg in generalized anxiety disorder: Results of an 8-week randomized, double-blind, placebo-controlled clinical trial in the United States

Rothschild, Anthony J., Mahableshwarkar, Atul R., Jacobsen, Paula, Yan, Mingjin, Sheehan, David V.

Journal:

European Neuropsychopharmacology

Year:

2012

Language:

english

File:

PDF, 422 KB

english, 2012

8

Editorial Board

Journal:

European Neuropsychopharmacology

Year:

2012

Language:

english

File:

PDF, 38 KB

english, 2012

9

ECNP Calendar of Events

Journal:

European Neuropsychopharmacology

Year:

2012

Language:

english

File:

PDF, 1.35 MB

english, 2012

10

Treatment of depression in first episode of schizophrenia: Results from EUFEST

Rybakowski, Janusz K., Vansteelandt, Kristof, Szafranski, Tomasz, Thys, Eric, Jarema, Marek, Wolfgang Fleischhacker, W., Kahn, René S., Peuskens, Joseph

Journal:

European Neuropsychopharmacology

Year:

2012

Language:

english

File:

PDF, 280 KB

english, 2012

12

Neuropsychopharmacology across brain diseases

Nutt, David J., Ove Ögren, Sven, van Ree, Jan M.

Journal:

European Neuropsychopharmacology

Year:

2012

Language:

english

File:

PDF, 160 KB

english, 2012

13

Patients' acceptance of the deltoid application of risperidone long-acting injection

Heres, Stephan, Frobose, Teresa, Hamann, Johannes, Leucht, Stefan, Maino, Katja, Reichhart, Tatjana, Stiegler, Michaela, Kissling, Werner

Journal:

European Neuropsychopharmacology

Year:

2012

Language:

english

File:

PDF, 209 KB

english, 2012

Volume 22; Issue 12

Psychiatric comorbidity of patients on methadone maintenance treatment with a history of sexual abuse

Vortioxetine (Lu AA21004) in generalized anxiety disorder: Results of an 8-week, multinational, randomized, double-blind, placebo-controlled clinical trial

On assessing potential efficacy for vortioxetine in generalized anxiety disorder

Pre-treatment waking cortisol response and vulnerability to interferon α induced depression

Detection of the acute effects of hydrocortisone in the hippocampus using pharmacological fMRI

Effects of novel, high affinity glycine transport inhibitors on frontostriatal dopamine release in a rodent model of schizophrenia

Vortioxetine (Lu AA21004) 5mg in generalized anxiety disorder: Results of an 8-week randomized, double-blind, placebo-controlled clinical trial in the United States

Editorial Board

ECNP Calendar of Events

Contents

Treatment of depression in first episode of schizophrenia: Results from EUFEST

Neuropsychopharmacology across brain diseases

Patients' acceptance of the deltoid application of risperidone long-acting injection